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Abstract
The expression of brain derived neurotrophic factor (BDNF) and its preferred receptor (TrkB) in rat retinal ganglion cells
(RGCs) have been determined in the present study. To identify RGCs retrograde labelling was performed with ﬂuorogold (FG).
Subsequently, retinas were immunostained with antibodies to BDNF and TrkB. We found that all RGCs labelled with FG express
both BDNF and its preferred receptor, TrkB. Moreover, displaced amacrine cells were also found to be immunolabelled by both
antibodies. Thus BDNF/TrkB signalling in RGCs probably involves endogenous BDNF produced by the RGCs themselves.
 2002 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Brain derived neurotrophic factor (BDNF) and its
receptor TrkB (Middlemas, Lindberg, & Hunter, 1991)
have been proposed to play an important role in
the neuroprotection of retinal ganglion cells (RGCs).
Recent studies have shown that exogenously applied
BDNF promotes the survival and prevents the death of
RGCs both in vivo, after axotomy (Mansour-Robaey,
Bray, & Aguayo, 1992; Mey & Thanos, 1993; Manosur-
Robaey et al., 1994; Peinado-Ramon, Salvador, Ville-
gas-Perez, & Vidal-Sanz, 1996), and in vitro (Johnson,
Barde, Schwab, & Thoenen, 1986; Thanos, B€arh, Barde,
& Vanselow, 1989). Moreover, exogenously applied
BDNF enhances optic axon branching in vivo (Cohen-
Cory & Fraser, 1995) and protects RGCs from ischemic
injury (Unoki & La Vail, 1994). Although these studies
suggest that exogenously applied BDNF can play an
important role in RGC survival, it is presently uncertain
if endogenous BDNF can also mediate neuroprotection
(Gao, Qiao, Hefti, Hollyﬁeld, & Knusel, 1997; Vecino,
Ugarte, Nash, & Osborne, 1999). Nevertheless the en-
dogenous levels of BDNF mRNA and protein in the
retina have been shown to be modulated by injury to the
optic nerve (Gao et al., 1997), by retinal ischemia,
(Vecino, Caminos, Ugarte, Martın-Zanca, & Osborne,
1998) and by injection of NMDA into the eye (Vecino
et al., 1999), suggesting that it may play some relevant
role following visual system injury.
The presence of BDNF in the RGC layer of the retina
was ﬁrst shown at the level of mRNA, by in situ hy-
bridisation (Qiao, Gao, & Hollyﬁeld, 1994) and later
at the level of protein synthesis (Vecino et al., 1998).
Moreover, the RGC layer of the retina also contains
cells which express the BDNF-preferring receptor TrkB,
at both the mRNA and protein level (Jelsma, Friedman,
Berkelaar, Bray, & Aguayo, 1993; Vecino et al., 1998).
BDNF action in the RGC may involve the activation
of the BDNF/TrkB ligand/receptor complex at nerve
terminals, and its subsequent internalisation and retro-
grade transport to the cell body. Indeed, interruption of
this retrograde transport of BDNF and TrkB in the
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optic nerve head may contribute to the damage observed
in acute and chronic glaucoma (Pease, McKinnon,
Quigley, Kerrigan-Baumrind, & Zack, 2000).
Although neurotrophins in the retina have been ex-
tensively studied, at the level of the developmental and
functional roles of these molecules, a precise descrip-
tion of the distribution of BDNF and its high aﬃnity
receptor TrkB in the RGC layer of the retina is still
lacking. The RGC layer contains ganglion cells, glial
cells and other cell types. It is estimated that approxi-
mately 50% of neurons in the ganglion cell layer of adult
rats are displaced amacrine cells (Perry, 1981). Thus, the
purpose of this study was to identify the population of
RGCs in the rat retina which express both BDNF and
the TrkB receptor.
The most suitable method currently used for identi-
fying the complete RGC population consists of labelling
these cells from their target in the brain using tracers,
such as ﬂuorogold (FG), which are retrogradely trans-
ported. Once the whole population of RGCs were thus
labelled, we immunostained retinas with antibodies to
BDNF or TrkB, in order to identify the population of
RGCs that express BDNF or TrkB. The presence of
double-labelled cells FG/BDNF or FG/TrkB was de-
termined in both sectioned and wholemounted retinas.
We clearly distinguished three diﬀerent sizes (small,
medium and large) of RGCs in retrogradely labelled,
wholemounted retinas. The morphology of these cell
groups largely corresponded to the alpha, beta and
gamma ganglion cell types. Moreover, we found that all
cells in the ganglion cell layer which were labelled with
FG also expressed BDNF and TrkB, indicating co-
expression of the ligand and its receptor in RGCs. In
addition, displaced RGCs observed in the inner nuclear
layer (INL), which constitute less than 1.5% of the total
population of RGCs, were also labelled with antibodies
to both the neurotrophin and its receptor.
2. Material and methods
2.1. Retrograde labelling of retinal ganglion cells
Eleven adult Sprague–Dawley rats (each weighing
225–250 g) were used in the present study. Rats were
housed in standard cages, fed ad libitum and maintained
in temperature-controlled rooms with a 12 h light–12 h
dark cycle. For all experimental manipulations, the ani-
mals were anaesthetised with intraperitoneal injections
of 7% chloral hydrate (0.42 mg/g body weight). Experi-
ments were carried out in accordance with the European
Union guidelines and the ARVO Statement for the use
of Animals in Ophthalmic and Vision Research.
To identify RGCs, we labelled them with the ﬂuo-
rescent tracer FG (Fluorochrome, Englewook CO) fol-
lowing previously described techniques (Villegas-Perez,
Vidal-Sanz, Bray, & Aguayo, 1988; Villegas-Perez,
Vidal-Sanz, Rasminsky, Bray, & Aguayo, 1993). Rats
were anaesthetised and the midbrain exposed. A small
piece of gelatine sponge (Sponhongostan Film, Ferron-
san, Denmark) soaked in 0.9% NaCl containing 3% FG
and 10% dimethylsulfoxide was laid over the superior
colliculi and lateral geniculate nuclei, both of which are
the targets of RGC axon projections. The animals were
allowed to recover and six days later were killed with an
overdose of anaesthetic and perfused through the as-
cending aorta with 0.9% NaCl followed by 4% para-
formaldehyde in 0.1 M phosphate-buﬀered saline (PBS).
Eyes were enucleated and the retinas were dissected,
prepared as wholemounts, postﬁxed for an additional
hour, and mounted, vitreal side up, on gelatine coated
slides. The ganglion cell layer was examined using ﬂuo-
rescence microscopy with an ultraviolet ﬁlter set. Once
the retinas were examined and the retrograde trans-
port to RGCs was conﬁrmed, some were prepared for
wholemount immunostaining with antisera to BDNF or
TrkB, while others were cryoprotected in 30% sucrose in
PBS, embedded in Tissue Tek (Leika) and sectioned at
14 lm in a cryostat.
2.2. Retinal ganglion cell counts
Mean densities of FG-labelled RGCs in the ganglion
cell layer of the retina were estimated following previ-
ously described methods (Villegas-Perez et al., 1993;
Laquis, Chaudhary, & Sharma, 1998). Brieﬂy, labelled
RGCs were counted by the same observer from photo-
graphs of 12 rectangular (0:36 0:24 mm2) areas of each
retina, three in each quadrant (superotemporal, infero-
temporal, superonasal, and inferonasal) at distances of
1, 2 and 3 mm from the optic disc. The number of la-
belled cells in the 12 photographs was divided by the
area of the region and pooled to calculate mean densities
of labelled neurons/mm2 for each retina.
2.3. Immunohistochemical procedure
Sectioned and wholemounted retinas were rinsed in
PBS containing 0.25% Triton X-100 (PBST), incubated
for 1 h at room temperature (RT) with blocking solution
containing PBST and 1% bovine serum albumin (BSA;
fraction V, Sigma). Sections were incubated overnight
at 4C with rabbit anti-BDNF (diluted to 1:200; Santa
Cruz #546) or rabbit anti-TrkB (diluted 1:100; Trans-
duction Laboratories #119) antisera. The wholemounted
retinas were incubated with antisera at the same dilution,
but with constant agitation at 4C for 48 h. After rinsing
in PBST, the retinas were incubated in goat anti-rabbit
IgG conjugated to Texas-red (diluted 1:200; Molecular
Probes). Sections were thus incubated for 1 h whereas
the whole free-ﬂoating retinas were incubated with sec-
ondary antibody for 4 h. Sections and wholemounts
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were rinsed in PBS and then coverslipped with PBS/
glycerol (1:1) and examined by epiﬂuorescence micros-
copy. After initial microscopic examination, some
wholemounted retinas were cryoprotected and sec-
tioned.
2.4. Immunohistochemical controls
Labelling speciﬁcity was assessed by (I) omission of
the primary antiserum, replacing it with PBST–BSA, (II)
omission of secondary antibody, (III) preadsorption
of primary antibodies with their respective antigenic
peptides (2–10 lg/ll of peptide) and (IV) heterologous
preadsorption, preadsorbing the anti-BDNF antiserum
with the TrkB peptide and the anti-TrkB antiserum with
the BDNF peptide.
3. Results
FG ﬂuorescence was found in the cytoplasm of RGC
somata and occasionally in the proximal dendrites of
these cells. Intense, homogenous FG labelling was ob-
served, in addition to a more punctate-type distribution
of label. Six days after FG application, the mean density
of the FG-labelled RGCs/mm2 was calculated to be
2420 50 (mean SEM). This mean density is com-
parable to estimates of rat RGC densities determined
with the same tracer or with other retrogradely trans-
ported ﬂuorescent tracers, similarly applied to the
retino-recipient targets (Villegas-Perez et al., 1988;
Peinado-Ramon et al., 1996).
The speciﬁcity of the antisera was demonstrated with
the controls which gave negative results in control cases
I, II and III, while in case IV, immunostaining was un-
altered, demonstrating that preadsorption under these
conditions was speciﬁc. Moreover, the speciﬁcity of these
antisera in the ﬁsh and rat retina has already been re-
ported (Vecino et al., 1998; Caminos, Becker, Martin-
Zanca, & Vecino, 1999).
In both the sectioned and wholemounted retinas, all
RGCs labelled with FG were also immunostained by the
antisera to BDNF (Figs. 1A–D and 2) and to TrkB (Fig.
1E and F). Thus we can conclude that in the retina of
the rat, both BDNF and its preferred receptor TrkB are
expressed in all RGCs (Fig. 1A and B). A number of
cells located in the RGC layer were BDNF immuno-
positive but were not FG immunolabelled. These cells
were presumably displaced amacrine cells (Figs. 1A, B,
and 2) BDNF and TrkB were also present in FG-posi-
tive cells located in the INL. These cells were evidently
displaced RGCs.
We found that BDNF and TrkB immunolabelled
cells could be classiﬁed into at least three groups, on the
basis of their size (<15 lm, 15–25 lm and larger than 25
lm; Fig. 2C and D). In addition, FG, BDNF and TrkB
immunolabelling was observed to be diﬀerentially lo-
cated within the cell body. Thus, while FG was located
in the perinuclear area of the soma, BDNF and TrkB
immunoreactivity was located in more peripheral cyto-
plasm and/or in the cytoplasmic membrane (Figs. 1 and
2). This diﬀerential distribution could be more clearly
observed when the corresponding images were super-
posed using the Adobe PhotoShop program (Fig. 3).
4. Discussion
In the present study we have shown that all, or at
least the vast majority of RGCs are retrogradely labelled
with FG and that they contain both BDNF and TrkB
immunoreactivity. These results, together with previous
in situ hybridisation experiments which demonstrated
the presence of BDNF and TrkB mRNAs in the RGC
layer, raise the possibility that locally produced BDNF
may play an important role in the activation of RGC
TrkB receptors in addition to the retrogradely trans-
ported ligand.
It is known that following optic nerve axotomy, cell
death can occur (Villegas-Perez et al., 1993) by apop-
tosis (Berkelaar, Clarke, Wang, Bray, & Aguayo, 1994;
Garcıa-Valenzuela, Gorczyca, Darzynkiewicz, & Shar-
ma, 1994). It has recently been shown that diﬀerent
RGC types have diﬀerent survival responses to injury
and regeneration (Thanos & Mey, 1995) with the large
alpha RGCs being more vulnerable to injury. Intravi-
treal injection of BDNF and other neurotrophic factors
favours the survival of RGCs after optic nerve axotomy
(Mansour-Robaey et al., 1992; Mey & Thanos, 1993;
Mansour-Robaey, Clarke, Wang, Bray, & Aguayo,
1994; Peinado-Ramon et al., 1996). In the present study,
we found that all RGCs express both BDNF and its
receptor, indicating that the diﬀerential responses of
RGCs to axotomy do not depend on the presence or
absence of BDNF or TrkB. Rather, RGC survival may
depend on there being a suﬃcient level of expression of
BDNF and its receptor in damaged cells post axotomy.
The observation that injection of BDNF into the eye
can lead to RGC rescue following trauma, supports this
hypothesis.
Retinal ischemia produces an elevation of extracel-
lular levels of glutamate in the retina, an interruption of
retrograde transport in the optic nerve and an obstruc-
tion of the arrival at the cell body of molecules required
for the survival of RGCs (Pease et al., 2000). Even when
this alteration in retrograde transport is present, retinal
ischemia induces an increase of BDNF protein synthesis
in RGCs, at least during the ﬁrst few hours after dam-
age, corroborating the idea of locally produced vs. ret-
rogradely transported BDNF. This increased synthesis
of BDNF may represent an endogenous neuroprotective
response by the RGCs (Vecino et al., 1998, 1999).
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However, after this initial response there is a decrease in
the expression of BDNF in RGCs which could be due to
an alteration in the metabolism of the aﬀected cells or
also to an interruption of the retrograde transport from
their target areas in the brain where neurons expressing
BDNF mRNA have been described (Wetmore, Ernfors,
Persson, & Olson, 1990; Friedman, Olson, & Persson,
1991; Conner, Lauterborn, Yang, Gall, & Varson, 1997).
Recent experiments have also demonstrated an accu-
mulation of TrkB in the optic nerve head after retinal
ischemia, possibly due to an interruption of the retro-
grade transport of the receptor (Pease et al., 2000). It
thus seems likely that both BDNF and TrkB can be
retrogradely transported to the rat retina from other
areas of the brain. However, as these authors failed to
ﬁnd TrkB in RGCs, it is possible that local, endogenous
synthesis may represent the principal source of TrkB
receptor in these cells.
Nevertheless, in the case of BDNF, anterograde
transport from other retinal cells to RGCs cannot be
ruled out since the anterograde transport of BDNF has
been reported in the central nervous system of the rat
(Altar et al., 1997; Conner et al., 1997; Altar & DiStef-
ano, 1998; Fawcett et al., 2000), and chick visual system
(von Bartheld et al., 1996; Herzog & von Bartheld, 1998).
Little is known about the mechanism by which FG
is retrogradely transported in neurons. However it has
been demonstrated that all or at least the vast majority
of RGCs are retrogradely labelled when FG is applied
to the targets of RGC axon projection areas of the brain
(Villegas-Perez et al., 1988, 1993) as in the present study.
In contrast, it is well known that BDNF is retrogradely
transported in association with TrkB. Recently it has
been demonstrated that BDNF is associated with vesi-
cular-like structures in both the cell body and proces-
ses of neurons. Diﬀerential centrifugation data have also
Fig. 1. Immunohistochemical distribution of BDNF, TrkB and FG in the rat retina. A and B illustrate BDNF-immunolabelled and FG-labelled
RGCs, respectively. The arrows point to a displaced RGC which presents both BDNF and FG. The asterisks indicate two displaced amacrine cells
which are not labelled with FG but are BDNF immunopositive. Scale bar, 25 lm. C and D are low-magniﬁcation photomicrographs of BDNF- and
FG-stained cells respectively. Note that in the INL, there are many BDNF immunoreactive cells. Scale bar, 25 lm. E and F are TrkB and FG-stained
cells respectively. The cytoplasmic nature of TrkB staining in RGCs is apparent. Scale bar, 25 lm. GCL (ganglion cell layer), IPL (inner plexiform
layer), INL (inner nuclear layer).
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shown that BDNF is present in microvesicles isolated
from a synaptosomal fraction. These data, taken to-
gether with the results of the present study are consistent
with the idea that BDNF produced in the neuron soma
is transported anterogradely, targeted towards the reg-
ulated secretory pathway and localised within the
presynaptic compartment of neurons as part of a se-
cretory mechanism for BDNF (Fawcett et al., 1997). We
observed a perinuclear distribution of FG (Fig. 1B), and
a more peripheral cytoplasmic distribution of BDNF
and TrkB (Fig. 1A). Further studies at the level of
electron microscopy will help us to elucidate the way in
which neurons store and transport neurotrophins and
other substances like FG.
The ubiquitous presence of BDNF immunoreactivity
in all size-classes of RGCs contrasts with the observa-
tion that only a low percentage of cells in the ganglion
cell layer express BDNF mRNA after axotomy (Gao
et al., 1997). Nevertheless, these diﬀerences are quite
likely due to alterations in mRNA synthesis following
axotomy.
In the present study, we have shown that both BDNF
and its preferred receptor TrkB are expressed by the
majority of rat RGCs, raising the possibility that BDNF/
TrkB signalling in rat RGCs may occur through auto-
crine/paracrine mechanisms. Our results indicate that
RGC vulnerability following injury is not due to the
absence of the receptor ligand complex but may be due
Fig. 2. Flat mounted retinas retrogradely labelled with FG (A and C) and immunolabelled with anti-BDNF antibodies (B and D). A and B represent
the same area of the retina. BDNF is clearly absent in cell nuclei, corroborating the speciﬁcity of the immunolabelling. Note that there are more
BDNF labelled RGCs (B) than FG stained cells (A). Scale bar for both photographs, 25 lm. C and D are high magniﬁcations of the same area of the
retina where the three diﬀerent sizes of RGCs labelled with FG in C and with BDNF in D are well represented. The asterisks indicate cells located in
the GCL which are not RGCs but which are BDNF immunoreactive. Scale bar, 25 lm.
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to insuﬃcient levels of expression of these molecules.
These ﬁndings of BDNF/TrkB expression on all RGCs,
including the subpopulation of displaced RGCs (1.5%
of the total population; Thanos, 1988), contribute to a
better understanding of RGCs which will be essential
in order to develop future clinical neuroprotective treat-
ments.
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